Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nanomix Corp NNMX

Healthcare Medical Devices
Nanomix Corporation is engaged in development of mobile point-of-care diagnostics. The Company operates through its Nanomix eLab System platform and assays that provide quantitative information for use in settings where time is critical to clinical decision-making and improved patient care. The platform is designed to provide rapid test results in a handheld device at the first point of patient... see more

Recent & Breaking News (OTCPK:NNMX)

Benchworks Collaborates With Boston Therapeutics to Market sugardown(R)

Marketwired September 29, 2014

Boston Therapeutics Appoints Meng Hee Tan, M.D. to Consulting Medical Director

Marketwired September 23, 2014

Boston Therapeutics Signs Clinical Trial Agreement With Prestigious Joslin Diabetes Center for Phase III Study of BTI-320

Marketwired September 22, 2014

Boston Therapeutics to Present Findings of BTI-320 as Therapy for Glycemic Control at 50th Annual Meeting of European Association for the Study of Diabetes

Marketwired September 16, 2014

Boston Therapeutics to Present at National Investment Banking Conference on September 16, 2014

Marketwired September 15, 2014

Boston Therapeutics to Present at Rodman & Renshaw Annual Global Investment Conference on September 10, 2014

Marketwired September 5, 2014

Boston Therapeutics Completes Enrollment of Patients With Type 2 Diabetes in Phase IIb Study on BTI-320 in the U.S.

Marketwired August 20, 2014

Boston Therapeutics Appoints Noted Diabetes Specialist Jaime A. Davidson, M.D. to Its Medical Advisory Board

Marketwired August 18, 2014

Boston Therapeutics Reports Corporate Update and Financial Results for the Second Quarter Ended June 30, 2014

Marketwired August 8, 2014

Boston Therapeutics Expands Medical Advisory Board

Marketwired August 5, 2014

Boston Therapeutics to Sponsor Symposium at American Chemical Society's Fall National Meeting in San Francisco

Marketwired July 30, 2014

Boston Therapeutics Appoints Zbigniew J. Witczak, Ph.D., to Its Scientific Advisory Board

Marketwired July 29, 2014

Boston Therapeutics Appoints Benjamin Rivnay, Ph.D. to Chief Scientist

Marketwired July 9, 2014

RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg

GlobeNewswire June 19, 2014

Boston Therapeutics Initiates Phase IIb Study to Assess the Efficacy and Safety of SUGARDOWN(R) for Type 2 Diabetes

Marketwired May 29, 2014

Boston Therapeutics to Present at SeeThruEquity Microcap Investor Conference on May 28 and Marcum Microcap Conference on May 29

Marketwired May 27, 2014

SeeThruEquity 3rd Annual Microcap Investor Conference To Be Held May 28, 2014

ACCESS Newswire May 22, 2014

SeeThruEquity Issues Quarterly Update on Boston Therapeutics and Raises Price Target to $1.12

ACCESS Newswire May 21, 2014

Boston Therapeutics Announces Strategic Marketing Agreement With Benchworks SD Aimed at Growing Sales of SUGARDOWN(R)

Marketwired May 20, 2014

Boston Therapeutics Reports Corporate Update and Financial Results for the First Quarter Ended March 31, 2014

Marketwired May 13, 2014